Eosinophilic Esophagitis: all 238 studies

Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.

• Fluticasone Versus Esomeprazole to Treat Eosinophilic EsophagitisCompletedNCT00895817Not applicableResults posted
• Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic EsophagitisCompletedNCT00880906Not applicableResults posted
• Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic EsophagitisCompletedNCT00762073Phase 2Results posted
• The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic EsophagitisCompletedNCT00728481Phase 2/3Results posted
• Use of Topical Budesonide in the Treatment of Eosinophilic EsophagitisCompletedNCT00638456Phase 2Results posted
• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisCompletedNCT00635089Phase 3Results posted
• Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 YearsCompletedNCT00538434Phase 2/3Results posted
• A Study of Flovent in Patients With Eosinophilic EsophagitisCompletedNCT00426283Phase 2Results posted
• Intravenous Mepolizumab In Children With Eosinophilic EsophagitisCompletedNCT00358449Phase 2Results posted
• Topical Steroid Treatment for Eosinophilic EsophagitisCompletedNCT00275561Phase 2Results posted
• A Pilot Study of the Treatment of Eosinophilic Esophagitis With OmalizumabCompletedNCT00123630Phase 2Results posted
• New Cases of EoE in Children in Poland.CompletedNCT07772388
• Surface EMG Testing on Swallowing in EoE PatientsActive, not recruitingNCT07156357
• BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)CompletedNCT07102329
• A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksActive, not recruitingNCT06851559Phase 2
• Patient-Centered Decision Support for Eosinophilic EsophagitisActive, not recruitingNCT06817213Not applicable
• A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareActive, not recruitingNCT06693531
• A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic EsophagitisActive, not recruitingNCT06598462Phase 2
• Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoEActive, not recruitingNCT06596252Phase 3
• Capsule Sponge Study in Eosinophilic OesophagitisCompletedNCT06501274Not applicable
• Dupilumab for Eosinophilic Esophagitis With Severe StricturesActive, not recruitingNCT06352073Phase 4
• A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)Active, not recruitingNCT06101095Phase 4
• A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveActive, not recruitingNCT05831176Phase 2
• A Study of CDX-0159 in Patients With Eosinophilic EsophagitisCompletedNCT05774184Phase 2
• A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic EsophagitisCompletedNCT05757856Phase 2
• Survey About the Relationship Beetween Allergic Rhinitis and Seasonal EOE ExacerbationsStatus unknownNCT05755477
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 3
• The Efficacy and Tolerability of 12-weeks Treatment With Almond and Buckwheat Based Formula in Pediatric Patients With Active EoEStatus unknownNCT05622214Not applicable
• A Study of Baked Milk Tolerance to Treat Eosinophilic EsophagtisCompletedNCT05606705Not applicable
• Evaluation of Efficacy, Safety and Patient' Satisfaction of Therapeutic Switch From Off-Steroids to BudesonideCompletedNCT05594849
• Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisActive, not recruitingNCT05583227Phase 3
• Systems Biology of Gastrointestinal and Related DiseasesTerminatedNCT05579444
• Mesalazine Oral Suspension in Active Eosinophilic EsophagitisCompletedNCT05488405Phase 2
• A Study of Detergents in the Pathogenesis of Eosinophilic EsophagitisCompletedNCT05482256Not applicable
• Comparison of Histology From a Mesh Sponge and Traditional Esophageal Biopsies in Children and Adolescents With EoEStatus unknownNCT05342168Not applicable
• Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in ChildrenActive, not recruitingNCT05309590
• Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)WithdrawnNCT05214599Phase 2
• A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic EsophagitisActive, not recruitingNCT05176262
• Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric PopulationActive, not recruitingNCT05176249
• A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving CendakimabCompletedNCT05175352Phase 1
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic DuodenitisWithdrawnNCT05152563Phase 3
• Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT05095116
• Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 TrialCompletedNCT05083312Phase 3
• Cow's Milk Elimination for Treatment of Eosinophilic EsophagitisActive, not recruitingNCT05083156
• The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)CompletedNCT04941742
• A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic EsophagitisCompletedNCT04849390Phase 2
• Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic EsophagitisWithdrawnNCT04835168Phase 1
• The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoEStatus unknownNCT04803162
• Endoscopic Characterisation of Inflammation in EoEStatus unknownNCT04769232Not applicable
• Swallowing Characteristics of Pediatric Patients With Eosinophilic EsophagitisCompletedNCT04704752
• Prostaglandin and Cannabinoid Receptors in EoECompletedNCT04626609
• Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic EsophagitisCompletedNCT04593251Phase 1
• Eosinophilic Esophagitis Steroid Safety StudyCompletedNCT04416217
• Pilot Study of Esocheck in Eosinophilic EsophagitisCompletedNCT04311970Not applicable
• Somatization, Anxiety, and Disordered Sleep in Pediatric Eosinophilic EsophagitisCompletedNCT04309786
• Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)CompletedNCT04281108Phase 3
• Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)Active, not recruitingNCT04149470Phase 4
• Radiation Dose in Humans From Orally Administered Tc99m-HeparinCompletedNCT04069429Early Phase 1
• Prospective Multicenter Nationwide Registry of Children With Eosinophilic EsophagitisStatus unknownNCT03858426
• Non-endoscopic Tracking of Disease Activity in Eosinophilic EsophagitisWithdrawnNCT03834298Not applicable
• Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic EsophagitisActive, not recruitingNCT03822325
• The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Pilot)CompletedNCT03812575
• Metabolomic Profiling of Eosinophilic EsophagitisWithdrawnNCT03803527Not applicable
• EoE RCT Fluticasone and Omeprazole vs Fluticasone AloneStatus unknownNCT03781596Phase 4
• A Food Additive Removal Diet for Pediatric Eosinophilic EsophagitisCompletedNCT03657771Not applicable
• Innate Immunity in Eosinophilic EsophagitisCompletedNCT03640975
• Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic EsophagitisWithdrawnNCT03615950
• Eating With Eosinophilic Esophagitis (EoE)CompletedNCT03581838
• Imaging of the Esophagus Using a SECM CapsuleWithdrawnNCT03546660Not applicable
• MRI to Assess Fibrosis in Eosinophilic Esophagitis PatientsTerminatedNCT03446118Not applicable
• CEGIR 7807: Validation of Online Cohort of EGID Patients Enrolled in RDCRN CEGIR Contact RegistryCompletedNCT03382678
• Short Duration 6Fed Sponge For EoE PatientsWithdrawnNCT03354221Not applicable
• CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in ChildrenCompletedNCT03342391Not applicable
• Natural History of Eosinophilic EsophagitisCompletedNCT03290482
• Metabolomics for Biomarker Discovery in Children With EoECompletedNCT03107819
• Sponge and Eosinophil Peroxidase (EPO) StainingCompletedNCT03078023Not applicable
• Phenotypic Characterization and Biomarkers Investigation for Eosinophilic Esophagitis in Pediatric PatientsCompletedNCT03069573
• Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)CompletedNCT02995395
• Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site CohortCompletedNCT02897271
• EoE Food DesensitizationWithdrawnNCT02881372Not applicable
• Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic EsophagitisCompletedNCT02775045
• a4b7 Integrin in Eosinophilic EsophagitisCompletedNCT02546219
• Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic EsophagitisCompletedNCT02493335Phase 3
• Food Antigen in Eosinophilic EsophagitisCompletedNCT02434705
• Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic EsophagitisCompletedNCT02434029Phase 3
• EndoFLIP Use in Upper GI Tract StenosisTerminatedNCT02354716
• The Effect of Sucralfate Slurry in Patients With Eosinophilic EsophagitisCompletedNCT02353078Early Phase 1
• Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.Status unknownNCT02331849Not applicable
• Mucosal Impedance in Pediatric PopulationCompletedNCT02320981
• Esophageal Absorption in EoETerminatedNCT02314455Not applicable
• Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic EsophagitisCompletedNCT02280616Phase 2
• Using Spectrally Encoded Confocal Microscopy (SECM) to Image the EsophagusActive, not recruitingNCT02202590Not applicable
• Prevalence of Eosinophilic Esophagitis in Children With Celiac DiseaseCompletedNCT02190513
• Comparison of Esophageal Clearance Times of Oral Budesonide PreparationsCompletedNCT02125851Not applicable
• Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.TerminatedNCT02113267Phase 2
• Dose Ranging Study of RPC4046 in Eosinophilic EsophagitisCompletedNCT02098473Phase 2
• Improved Diagnostics of Celiac Disease in ChildrenCompletedNCT02072590
• Esophageal String Test in Eosinophilic EsophagitisActive, not recruitingNCT02008903
• EoE(Eosinophilic Esophagitis)CompletedNCT01999439Not applicable
• Risk Factors and Biomarkers for Diagnosis and Treatment of EoECompletedNCT01988285

← Eosinophilic Esophagitis overview